Coloplast A/S
Coloplast A/S (CLPBY) Stock Competitors & Peer Comparison
See (CLPBY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLPBY | $6.36 | +0.79% | 14.2B | 42.04 | $0.15 | +5.73% |
| SEMHF | $40.47 | -0.53% | 44.7B | 18.16 | $2.20 | +2.98% |
| RSMDF | $17.93 | +0.00% | 26B | 17.24 | $1.04 | +1.15% |
| RYLPF | $26.98 | +1.22% | 24.3B | 21.98 | $1.16 | +3.90% |
| FUJIF | $20.00 | +0.00% | 23.9B | 14.18 | $1.41 | +2.28% |
| FUJIY | $10.01 | +0.64% | 23.8B | 13.92 | $0.71 | +3.08% |
| SMMNY | $20.36 | +1.87% | 22.5B | 18.29 | $1.10 | +2.96% |
| SONVF | $268.00 | +2.25% | 15.9B | 23.43 | $11.44 | +2.02% |
| SONVY | $53.29 | +0.28% | 15.7B | 23.10 | $2.29 | +2.04% |
| SNNUF | $14.95 | +0.27% | 12.7B | 20.76 | $0.72 | +2.60% |
Stock Comparison
CLPBY vs SEMHF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, SEMHF has a market cap of 44.7B. Regarding current trading prices, CLPBY is priced at $6.36, while SEMHF trades at $40.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas SEMHF's P/E ratio is 18.16. In terms of profitability, CLPBY's ROE is +0.14%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, CLPBY is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check SEMHF's competition here
CLPBY vs RSMDF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, RSMDF has a market cap of 26B. Regarding current trading prices, CLPBY is priced at $6.36, while RSMDF trades at $17.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas RSMDF's P/E ratio is 17.24. In terms of profitability, CLPBY's ROE is +0.14%, compared to RSMDF's ROE of +0.24%. Regarding short-term risk, CLPBY is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check RSMDF's competition here
CLPBY vs RYLPF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, RYLPF has a market cap of 24.3B. Regarding current trading prices, CLPBY is priced at $6.36, while RYLPF trades at $26.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas RYLPF's P/E ratio is 21.98. In terms of profitability, CLPBY's ROE is +0.14%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, CLPBY is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check RYLPF's competition here
CLPBY vs FUJIF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, FUJIF has a market cap of 23.9B. Regarding current trading prices, CLPBY is priced at $6.36, while FUJIF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas FUJIF's P/E ratio is 14.18. In terms of profitability, CLPBY's ROE is +0.14%, compared to FUJIF's ROE of +0.10%. Regarding short-term risk, CLPBY is more volatile compared to FUJIF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check FUJIF's competition here
CLPBY vs FUJIY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, FUJIY has a market cap of 23.8B. Regarding current trading prices, CLPBY is priced at $6.36, while FUJIY trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas FUJIY's P/E ratio is 13.92. In terms of profitability, CLPBY's ROE is +0.14%, compared to FUJIY's ROE of +0.08%. Regarding short-term risk, CLPBY is less volatile compared to FUJIY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check FUJIY's competition here
CLPBY vs SMMNY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, SMMNY has a market cap of 22.5B. Regarding current trading prices, CLPBY is priced at $6.36, while SMMNY trades at $20.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas SMMNY's P/E ratio is 18.29. In terms of profitability, CLPBY's ROE is +0.14%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, CLPBY is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check SMMNY's competition here
CLPBY vs SONVF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, SONVF has a market cap of 15.9B. Regarding current trading prices, CLPBY is priced at $6.36, while SONVF trades at $268.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas SONVF's P/E ratio is 23.43. In terms of profitability, CLPBY's ROE is +0.14%, compared to SONVF's ROE of +0.21%. Regarding short-term risk, CLPBY is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check SONVF's competition here
CLPBY vs SONVY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, SONVY has a market cap of 15.7B. Regarding current trading prices, CLPBY is priced at $6.36, while SONVY trades at $53.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas SONVY's P/E ratio is 23.10. In terms of profitability, CLPBY's ROE is +0.14%, compared to SONVY's ROE of +0.22%. Regarding short-term risk, CLPBY is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check SONVY's competition here
CLPBY vs SNNUF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, SNNUF has a market cap of 12.7B. Regarding current trading prices, CLPBY is priced at $6.36, while SNNUF trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas SNNUF's P/E ratio is 20.76. In terms of profitability, CLPBY's ROE is +0.14%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, CLPBY is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check SNNUF's competition here
CLPBY vs CLPBF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CLPBF has a market cap of 12.7B. Regarding current trading prices, CLPBY is priced at $6.36, while CLPBF trades at $61.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CLPBF's P/E ratio is 42.32. In terms of profitability, CLPBY's ROE is +0.14%, compared to CLPBF's ROE of +0.14%. Regarding short-term risk, CLPBY is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check CLPBF's competition here
CLPBY vs OCPNF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, OCPNF has a market cap of 12.3B. Regarding current trading prices, CLPBY is priced at $6.36, while OCPNF trades at $11.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas OCPNF's P/E ratio is 28.67. In terms of profitability, CLPBY's ROE is +0.14%, compared to OCPNF's ROE of +0.09%. Regarding short-term risk, CLPBY is more volatile compared to OCPNF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check OCPNF's competition here
CLPBY vs WILYY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, WILYY has a market cap of 8.1B. Regarding current trading prices, CLPBY is priced at $6.36, while WILYY trades at $19.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas WILYY's P/E ratio is 22.13. In terms of profitability, CLPBY's ROE is +0.14%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, CLPBY is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check WILYY's competition here
CLPBY vs WILLF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, WILLF has a market cap of 7.5B. Regarding current trading prices, CLPBY is priced at $6.36, while WILLF trades at $35.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas WILLF's P/E ratio is 20.37. In terms of profitability, CLPBY's ROE is +0.14%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, CLPBY is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check WILLF's competition here
CLPBY vs GNGBY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, GNGBY has a market cap of 5.6B. Regarding current trading prices, CLPBY is priced at $6.36, while GNGBY trades at $20.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas GNGBY's P/E ratio is 22.22. In terms of profitability, CLPBY's ROE is +0.14%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, CLPBY is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check GNGBY's competition here
CLPBY vs GNGBF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, CLPBY is priced at $6.36, while GNGBF trades at $20.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas GNGBF's P/E ratio is 21.79. In terms of profitability, CLPBY's ROE is +0.14%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, CLPBY is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check GNGBF's competition here
CLPBY vs YPHDF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, CLPBY is priced at $6.36, while YPHDF trades at $367.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas YPHDF's P/E ratio is 17.78. In terms of profitability, CLPBY's ROE is +0.14%, compared to YPHDF's ROE of +0.38%. Regarding short-term risk, CLPBY is more volatile compared to YPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check YPHDF's competition here
CLPBY vs CHEOY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CHEOY has a market cap of 4.5B. Regarding current trading prices, CLPBY is priced at $6.36, while CHEOY trades at $34.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CHEOY's P/E ratio is 18.48. In terms of profitability, CLPBY's ROE is +0.14%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, CLPBY is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check CHEOY's competition here
CLPBY vs CHEOF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CHEOF has a market cap of 4.5B. Regarding current trading prices, CLPBY is priced at $6.36, while CHEOF trades at $68.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CHEOF's P/E ratio is 18.13. In terms of profitability, CLPBY's ROE is +0.14%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, CLPBY is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check CHEOF's competition here
CLPBY vs NHNKY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, NHNKY has a market cap of 2.8B. Regarding current trading prices, CLPBY is priced at $6.36, while NHNKY trades at $9.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas NHNKY's P/E ratio is 15.83. In terms of profitability, CLPBY's ROE is +0.14%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, CLPBY is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check NHNKY's competition here
CLPBY vs AMFPF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, AMFPF has a market cap of 2.6B. Regarding current trading prices, CLPBY is priced at $6.36, while AMFPF trades at $12.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas AMFPF's P/E ratio is 33.36. In terms of profitability, CLPBY's ROE is +0.14%, compared to AMFPF's ROE of +0.07%. Regarding short-term risk, CLPBY is more volatile compared to AMFPF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check AMFPF's competition here
CLPBY vs AMBBY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, AMBBY has a market cap of 2.6B. Regarding current trading prices, CLPBY is priced at $6.36, while AMBBY trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas AMBBY's P/E ratio is 35.64. In terms of profitability, CLPBY's ROE is +0.14%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, CLPBY is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check AMBBY's competition here
CLPBY vs AMBFF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, AMBFF has a market cap of 2.6B. Regarding current trading prices, CLPBY is priced at $6.36, while AMBFF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas AMBFF's P/E ratio is 35.36. In terms of profitability, CLPBY's ROE is +0.14%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, CLPBY is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check AMBFF's competition here
CLPBY vs GNNDY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, CLPBY is priced at $6.36, while GNNDY trades at $45.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas GNNDY's P/E ratio is 54.36. In terms of profitability, CLPBY's ROE is +0.14%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, CLPBY is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check GNNDY's competition here
CLPBY vs OSSFF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, CLPBY is priced at $6.36, while OSSFF trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas OSSFF's P/E ratio is 25.55. In terms of profitability, CLPBY's ROE is +0.14%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, CLPBY is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check OSSFF's competition here
CLPBY vs MCRPF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, CLPBY is priced at $6.36, while MCRPF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas MCRPF's P/E ratio is -12.67. In terms of profitability, CLPBY's ROE is +0.14%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, CLPBY is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check MCRPF's competition here
CLPBY vs DRWKF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, CLPBY is priced at $6.36, while DRWKF trades at $111.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas DRWKF's P/E ratio is 11.79. In terms of profitability, CLPBY's ROE is +0.14%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, CLPBY is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check DRWKF's competition here
CLPBY vs GGNDF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, CLPBY is priced at $6.36, while GGNDF trades at $14.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas GGNDF's P/E ratio is 51.25. In terms of profitability, CLPBY's ROE is +0.14%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, CLPBY is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check GGNDF's competition here
CLPBY vs OSSUY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, OSSUY has a market cap of 1.8B. Regarding current trading prices, CLPBY is priced at $6.36, while OSSUY trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas OSSUY's P/E ratio is 20.65. In terms of profitability, CLPBY's ROE is +0.14%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, CLPBY is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check OSSUY's competition here
CLPBY vs DWRKF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, CLPBY is priced at $6.36, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, CLPBY's ROE is +0.14%, compared to DWRKF's ROE of N/A. Regarding short-term risk, CLPBY is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check DWRKF's competition here
CLPBY vs NHNKF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, NHNKF has a market cap of 1.7B. Regarding current trading prices, CLPBY is priced at $6.36, while NHNKF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas NHNKF's P/E ratio is 30.28. In terms of profitability, CLPBY's ROE is +0.14%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, CLPBY is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check NHNKF's competition here
CLPBY vs MEDGF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, CLPBY is priced at $6.36, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, CLPBY's ROE is +0.14%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, CLPBY is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check MEDGF's competition here
CLPBY vs BOEUF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, CLPBY is priced at $6.36, while BOEUF trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas BOEUF's P/E ratio is 83.30. In terms of profitability, CLPBY's ROE is +0.14%, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, CLPBY is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check BOEUF's competition here
CLPBY vs VTRLY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, CLPBY is priced at $6.36, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas VTRLY's P/E ratio is -2.78. In terms of profitability, CLPBY's ROE is +0.14%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, CLPBY is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check VTRLY's competition here
CLPBY vs MDRSF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, CLPBY is priced at $6.36, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, CLPBY's ROE is +0.14%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, CLPBY is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check MDRSF's competition here
CLPBY vs DGWPF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, DGWPF has a market cap of 1.4B. Regarding current trading prices, CLPBY is priced at $6.36, while DGWPF trades at $72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas DGWPF's P/E ratio is 7.61. In terms of profitability, CLPBY's ROE is +0.14%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, CLPBY is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check DGWPF's competition here
CLPBY vs FDMDF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, FDMDF has a market cap of 1.3B. Regarding current trading prices, CLPBY is priced at $6.36, while FDMDF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas FDMDF's P/E ratio is -7.76. In terms of profitability, CLPBY's ROE is +0.14%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, CLPBY is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check FDMDF's competition here
CLPBY vs XVIPF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, XVIPF has a market cap of 925.8M. Regarding current trading prices, CLPBY is priced at $6.36, while XVIPF trades at $29.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas XVIPF's P/E ratio is 117.56. In terms of profitability, CLPBY's ROE is +0.14%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, CLPBY is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check XVIPF's competition here
CLPBY vs LFTSF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, CLPBY is priced at $6.36, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, CLPBY's ROE is +0.14%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, CLPBY is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check LFTSF's competition here
CLPBY vs ELEAF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, CLPBY is priced at $6.36, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas ELEAF's P/E ratio is 12.31. In terms of profitability, CLPBY's ROE is +0.14%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, CLPBY is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check ELEAF's competition here
CLPBY vs BRSYF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, BRSYF has a market cap of 542.7M. Regarding current trading prices, CLPBY is priced at $6.36, while BRSYF trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas BRSYF's P/E ratio is 61.59. In terms of profitability, CLPBY's ROE is +0.14%, compared to BRSYF's ROE of +0.12%. Regarding short-term risk, CLPBY is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check BRSYF's competition here
CLPBY vs CALZF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CALZF has a market cap of 529.4M. Regarding current trading prices, CLPBY is priced at $6.36, while CALZF trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CALZF's P/E ratio is 76.62. In terms of profitability, CLPBY's ROE is +0.14%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, CLPBY is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check CALZF's competition here
CLPBY vs IOBCF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, IOBCF has a market cap of 501.5M. Regarding current trading prices, CLPBY is priced at $6.36, while IOBCF trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas IOBCF's P/E ratio is 34.90. In terms of profitability, CLPBY's ROE is +0.14%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, CLPBY is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check IOBCF's competition here
CLPBY vs AVMR Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, CLPBY is priced at $6.36, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas AVMR's P/E ratio is -18.34. In terms of profitability, CLPBY's ROE is +0.14%, compared to AVMR's ROE of -0.23%. Regarding short-term risk, CLPBY is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check AVMR's competition here
CLPBY vs DMTRF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, CLPBY is priced at $6.36, while DMTRF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, CLPBY's ROE is +0.14%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, CLPBY is more volatile compared to DMTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check DMTRF's competition here
CLPBY vs HYBT Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, CLPBY is priced at $6.36, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas HYBT's P/E ratio is N/A. In terms of profitability, CLPBY's ROE is +0.14%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, CLPBY is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check HYBT's competition here
CLPBY vs CLVSF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, CLPBY is priced at $6.36, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CLVSF's P/E ratio is 22.48. In terms of profitability, CLPBY's ROE is +0.14%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, CLPBY is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check CLVSF's competition here
CLPBY vs CYBQY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CYBQY has a market cap of 294.3M. Regarding current trading prices, CLPBY is priced at $6.36, while CYBQY trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CYBQY's P/E ratio is -165.00. In terms of profitability, CLPBY's ROE is +0.14%, compared to CYBQY's ROE of +0.01%. Regarding short-term risk, CLPBY is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check CYBQY's competition here
CLPBY vs CSSPF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CSSPF has a market cap of 273.5M. Regarding current trading prices, CLPBY is priced at $6.36, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CSSPF's P/E ratio is 32.50. In terms of profitability, CLPBY's ROE is +0.14%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, CLPBY is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check CSSPF's competition here
CLPBY vs HTLZF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, CLPBY is priced at $6.36, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, CLPBY's ROE is +0.14%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, CLPBY is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check HTLZF's competition here
CLPBY vs IMPZY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, CLPBY is priced at $6.36, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, CLPBY's ROE is +0.14%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, CLPBY is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check IMPZY's competition here
CLPBY vs EBRCZ Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, EBRCZ has a market cap of 229.2M. Regarding current trading prices, CLPBY is priced at $6.36, while EBRCZ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas EBRCZ's P/E ratio is -1.40. In terms of profitability, CLPBY's ROE is +0.14%, compared to EBRCZ's ROE of -1.80%. Regarding short-term risk, CLPBY is more volatile compared to EBRCZ. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check EBRCZ's competition here
CLPBY vs CYBQF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CYBQF has a market cap of 206.8M. Regarding current trading prices, CLPBY is priced at $6.36, while CYBQF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CYBQF's P/E ratio is -155.00. In terms of profitability, CLPBY's ROE is +0.14%, compared to CYBQF's ROE of +0.00%. Regarding short-term risk, CLPBY is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check CYBQF's competition here
CLPBY vs XVIPY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, XVIPY has a market cap of 206M. Regarding current trading prices, CLPBY is priced at $6.36, while XVIPY trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas XVIPY's P/E ratio is N/A. In terms of profitability, CLPBY's ROE is +0.14%, compared to XVIPY's ROE of +0.01%. Regarding short-term risk, CLPBY is more volatile compared to XVIPY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check XVIPY's competition here
CLPBY vs VMTHF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, CLPBY is priced at $6.36, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, CLPBY's ROE is +0.14%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, CLPBY is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check VMTHF's competition here
CLPBY vs BCCOY Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, BCCOY has a market cap of 183.5M. Regarding current trading prices, CLPBY is priced at $6.36, while BCCOY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas BCCOY's P/E ratio is -1.16. In terms of profitability, CLPBY's ROE is +0.14%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, CLPBY is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check BCCOY's competition here
CLPBY vs DTXMF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, CLPBY is priced at $6.36, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, CLPBY's ROE is +0.14%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, CLPBY is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check DTXMF's competition here
CLPBY vs EKDHF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, EKDHF has a market cap of 167.9M. Regarding current trading prices, CLPBY is priced at $6.36, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas EKDHF's P/E ratio is 39.00. In terms of profitability, CLPBY's ROE is +0.14%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, CLPBY is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check EKDHF's competition here
CLPBY vs EAPIF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, EAPIF has a market cap of 162.8M. Regarding current trading prices, CLPBY is priced at $6.36, while EAPIF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas EAPIF's P/E ratio is -0.66. In terms of profitability, CLPBY's ROE is +0.14%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, CLPBY is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check EAPIF's competition here
CLPBY vs BRNHF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, BRNHF has a market cap of 161.7M. Regarding current trading prices, CLPBY is priced at $6.36, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, CLPBY's ROE is +0.14%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, CLPBY is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check BRNHF's competition here
CLPBY vs JMDMF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, JMDMF has a market cap of 156.4M. Regarding current trading prices, CLPBY is priced at $6.36, while JMDMF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas JMDMF's P/E ratio is -22.73. In terms of profitability, CLPBY's ROE is +0.14%, compared to JMDMF's ROE of N/A. Regarding short-term risk, CLPBY is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check JMDMF's competition here
CLPBY vs CLLKF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CLLKF has a market cap of 136.8M. Regarding current trading prices, CLPBY is priced at $6.36, while CLLKF trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CLLKF's P/E ratio is -0.89. In terms of profitability, CLPBY's ROE is +0.14%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, CLPBY is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check CLLKF's competition here
CLPBY vs AMEUF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, CLPBY is priced at $6.36, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, CLPBY's ROE is +0.14%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, CLPBY is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check AMEUF's competition here
CLPBY vs PXMBF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, PXMBF has a market cap of 119.9M. Regarding current trading prices, CLPBY is priced at $6.36, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, CLPBY's ROE is +0.14%, compared to PXMBF's ROE of -0.03%. Regarding short-term risk, CLPBY is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check PXMBF's competition here
CLPBY vs SNZZF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, SNZZF has a market cap of 110.1M. Regarding current trading prices, CLPBY is priced at $6.36, while SNZZF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas SNZZF's P/E ratio is -7.78. In terms of profitability, CLPBY's ROE is +0.14%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, CLPBY is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check SNZZF's competition here
CLPBY vs SOMNF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, CLPBY is priced at $6.36, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, CLPBY's ROE is +0.14%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, CLPBY is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check SOMNF's competition here
CLPBY vs RSHUF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, CLPBY is priced at $6.36, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, CLPBY's ROE is +0.14%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, CLPBY is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check RSHUF's competition here
CLPBY vs AVHHL Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, AVHHL has a market cap of 90.1M. Regarding current trading prices, CLPBY is priced at $6.36, while AVHHL trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas AVHHL's P/E ratio is -2.34. In terms of profitability, CLPBY's ROE is +0.14%, compared to AVHHL's ROE of +3.05%. Regarding short-term risk, CLPBY is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check AVHHL's competition here
CLPBY vs CKMTF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, CLPBY is priced at $6.36, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, CLPBY's ROE is +0.14%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, CLPBY is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check CKMTF's competition here
CLPBY vs BLOZF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, BLOZF has a market cap of 60.2M. Regarding current trading prices, CLPBY is priced at $6.36, while BLOZF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas BLOZF's P/E ratio is -12.28. In terms of profitability, CLPBY's ROE is +0.14%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, CLPBY is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check BLOZF's competition here
CLPBY vs TLTFF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, TLTFF has a market cap of 49.3M. Regarding current trading prices, CLPBY is priced at $6.36, while TLTFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas TLTFF's P/E ratio is -17.87. In terms of profitability, CLPBY's ROE is +0.14%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, CLPBY is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check TLTFF's competition here
CLPBY vs ACIXF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, ACIXF has a market cap of 35M. Regarding current trading prices, CLPBY is priced at $6.36, while ACIXF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas ACIXF's P/E ratio is -3.11. In terms of profitability, CLPBY's ROE is +0.14%, compared to ACIXF's ROE of -1.06%. Regarding short-term risk, CLPBY is less volatile compared to ACIXF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check ACIXF's competition here
CLPBY vs NVYTF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, CLPBY is priced at $6.36, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, CLPBY's ROE is +0.14%, compared to NVYTF's ROE of -1.22%. Regarding short-term risk, CLPBY is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check NVYTF's competition here
CLPBY vs RDGL Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, RDGL has a market cap of 32.2M. Regarding current trading prices, CLPBY is priced at $6.36, while RDGL trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas RDGL's P/E ratio is -6.52. In terms of profitability, CLPBY's ROE is +0.14%, compared to RDGL's ROE of -1.48%. Regarding short-term risk, CLPBY is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check RDGL's competition here
CLPBY vs POSC Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, POSC has a market cap of 26.4M. Regarding current trading prices, CLPBY is priced at $6.36, while POSC trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas POSC's P/E ratio is -5.61. In terms of profitability, CLPBY's ROE is +0.14%, compared to POSC's ROE of -7.67%. Regarding short-term risk, CLPBY is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check POSC's competition here
CLPBY vs MKEAF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, CLPBY is priced at $6.36, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, CLPBY's ROE is +0.14%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, CLPBY is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check MKEAF's competition here
CLPBY vs PYNKF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, PYNKF has a market cap of 25.7M. Regarding current trading prices, CLPBY is priced at $6.36, while PYNKF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas PYNKF's P/E ratio is 4.08. In terms of profitability, CLPBY's ROE is +0.14%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, CLPBY is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check PYNKF's competition here
CLPBY vs TCLIF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, CLPBY is priced at $6.36, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, CLPBY's ROE is +0.14%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, CLPBY is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check TCLIF's competition here
CLPBY vs KBBTF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, CLPBY is priced at $6.36, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, CLPBY's ROE is +0.14%, compared to KBBTF's ROE of N/A. Regarding short-term risk, CLPBY is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check KBBTF's competition here
CLPBY vs EMITF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, CLPBY is priced at $6.36, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas EMITF's P/E ratio is -7.62. In terms of profitability, CLPBY's ROE is +0.14%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, CLPBY is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check EMITF's competition here
CLPBY vs DIZTF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, CLPBY is priced at $6.36, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, CLPBY's ROE is +0.14%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, CLPBY is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check DIZTF's competition here
CLPBY vs VPTDF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, VPTDF has a market cap of 17.8M. Regarding current trading prices, CLPBY is priced at $6.36, while VPTDF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas VPTDF's P/E ratio is -9.50. In terms of profitability, CLPBY's ROE is +0.14%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, CLPBY is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check VPTDF's competition here
CLPBY vs GTHP Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, GTHP has a market cap of 14.6M. Regarding current trading prices, CLPBY is priced at $6.36, while GTHP trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas GTHP's P/E ratio is -4.75. In terms of profitability, CLPBY's ROE is +0.14%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, CLPBY is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check GTHP's competition here
CLPBY vs MDXHF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, CLPBY is priced at $6.36, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, CLPBY's ROE is +0.14%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, CLPBY is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check MDXHF's competition here
CLPBY vs IPDQF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, IPDQF has a market cap of 14.3M. Regarding current trading prices, CLPBY is priced at $6.36, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas IPDQF's P/E ratio is -0.70. In terms of profitability, CLPBY's ROE is +0.14%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, CLPBY is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check IPDQF's competition here
CLPBY vs ASAPF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, ASAPF has a market cap of 14M. Regarding current trading prices, CLPBY is priced at $6.36, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas ASAPF's P/E ratio is -17.99. In terms of profitability, CLPBY's ROE is +0.14%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, CLPBY is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check ASAPF's competition here
CLPBY vs TMDIF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, CLPBY is priced at $6.36, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, CLPBY's ROE is +0.14%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, CLPBY is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check TMDIF's competition here
CLPBY vs ATBPF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, CLPBY is priced at $6.36, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, CLPBY's ROE is +0.14%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, CLPBY is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check ATBPF's competition here
CLPBY vs LXXGF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, CLPBY is priced at $6.36, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, CLPBY's ROE is +0.14%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, CLPBY is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check LXXGF's competition here
CLPBY vs ALRTF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, ALRTF has a market cap of 9.7M. Regarding current trading prices, CLPBY is priced at $6.36, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas ALRTF's P/E ratio is -0.37. In terms of profitability, CLPBY's ROE is +0.14%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, CLPBY is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check ALRTF's competition here
CLPBY vs PLLWF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, CLPBY is priced at $6.36, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, CLPBY's ROE is +0.14%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, CLPBY is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check PLLWF's competition here
CLPBY vs BIEL Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, BIEL has a market cap of 6.3M. Regarding current trading prices, CLPBY is priced at $6.36, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas BIEL's P/E ratio is N/A. In terms of profitability, CLPBY's ROE is +0.14%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, CLPBY is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check BIEL's competition here
CLPBY vs PMEDF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, PMEDF has a market cap of 6.1M. Regarding current trading prices, CLPBY is priced at $6.36, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas PMEDF's P/E ratio is -2.97. In terms of profitability, CLPBY's ROE is +0.14%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, CLPBY is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check PMEDF's competition here
CLPBY vs USAQ Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, USAQ has a market cap of 5.7M. Regarding current trading prices, CLPBY is priced at $6.36, while USAQ trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas USAQ's P/E ratio is 15.46. In terms of profitability, CLPBY's ROE is +0.14%, compared to USAQ's ROE of +0.92%. Regarding short-term risk, CLPBY is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check USAQ's competition here
CLPBY vs QLIS Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, CLPBY is priced at $6.36, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas QLIS's P/E ratio is 2.22. In terms of profitability, CLPBY's ROE is +0.14%, compared to QLIS's ROE of -0.15%. Regarding short-term risk, CLPBY is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for CLPBY.Check QLIS's competition here
CLPBY vs RHNMF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, CLPBY is priced at $6.36, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, CLPBY's ROE is +0.14%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, CLPBY is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check RHNMF's competition here
CLPBY vs ADMT Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, ADMT has a market cap of 4.6M. Regarding current trading prices, CLPBY is priced at $6.36, while ADMT trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas ADMT's P/E ratio is -6.77. In terms of profitability, CLPBY's ROE is +0.14%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, CLPBY is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check ADMT's competition here
CLPBY vs NGMDF Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, NGMDF has a market cap of 3.7M. Regarding current trading prices, CLPBY is priced at $6.36, while NGMDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas NGMDF's P/E ratio is -0.55. In terms of profitability, CLPBY's ROE is +0.14%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, CLPBY is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check NGMDF's competition here
CLPBY vs LLBO Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, LLBO has a market cap of 3.5M. Regarding current trading prices, CLPBY is priced at $6.36, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas LLBO's P/E ratio is N/A. In terms of profitability, CLPBY's ROE is +0.14%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, CLPBY is less volatile compared to LLBO. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check LLBO's competition here
CLPBY vs RMSL Comparison May 2026
CLPBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPBY stands at 14.2B. In comparison, RMSL has a market cap of 3.4M. Regarding current trading prices, CLPBY is priced at $6.36, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPBY currently has a P/E ratio of 42.04, whereas RMSL's P/E ratio is 0.20. In terms of profitability, CLPBY's ROE is +0.14%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, CLPBY is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for CLPBY.Check RMSL's competition here